company background image
CD5N logo

Inuvo DB:CD5N Stock Report

Last Price

€0.51

Market Cap

€87.7m

7D

25.4%

1Y

27.8%

Updated

01 Jan, 2025

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Inuvo, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Inuvo
Historical stock prices
Current Share PriceUS$0.51
52 Week HighUS$0.51
52 Week LowUS$0.17
Beta1.2
1 Month Change60.63%
3 Month Change143.86%
1 Year Change27.78%
3 Year Change8.12%
5 Year Change96.12%
Change since IPO-75.44%

Recent News & Updates

Recent updates

Shareholder Returns

CD5NDE SoftwareDE Market
7D25.4%-0.06%0.3%
1Y27.8%66.4%6.9%

Return vs Industry: CD5N underperformed the German Software industry which returned 63.7% over the past year.

Return vs Market: CD5N exceeded the German Market which returned 6.9% over the past year.

Price Volatility

Is CD5N's price volatile compared to industry and market?
CD5N volatility
CD5N Average Weekly Movement19.7%
Software Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.7%
10% least volatile stocks in DE Market2.4%

Stable Share Price: CD5N's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: CD5N's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a82Rich Howeinuvo.com

Inuvo, Inc. engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). Its platforms optimize the purchase and placement of advertising in real time.

Inuvo, Inc. Fundamentals Summary

How do Inuvo's earnings and revenue compare to its market cap?
CD5N fundamental statistics
Market cap€87.67m
Earnings (TTM)-€8.02m
Revenue (TTM)€75.72m

1.2x

P/S Ratio

-10.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CD5N income statement (TTM)
RevenueUS$78.45m
Cost of RevenueUS$10.24m
Gross ProfitUS$68.20m
Other ExpensesUS$76.51m
Earnings-US$8.30m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.059
Gross Margin86.94%
Net Profit Margin-10.59%
Debt/Equity Ratio0%

How did CD5N perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/01 09:27
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Inuvo, Inc. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael RindosAegis Capital Corporation
Brian KinstlingerAlliance Global Partners
Eric MartinuzziCraig-Hallum Capital Group LLC